GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
46 hedge funds and large institutions have $79.4M invested in Genocea Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $86.3M → $79.4M (-$6.89M)
Holders
46
Holding in Top 10
2
Calls
$843K
Puts
$200K
Top Buyers
| 1 | +$5.85M | |
| 2 | +$284K | |
| 3 | +$164K | |
| 4 |
CC
Commodore Capital
New York
|
+$135K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$102K |
Top Sellers
| 1 | -$548K | |
| 2 | -$514K | |
| 3 | -$365K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$347K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$219K |